Ciloa Secures €5 Million for the Development of Its New Generation of Biomedicines and Vaccines Using Exosomes
The company finalized a €3.5 million fundraising and obtained €1.5 million in public funding as part of the "Emerging Infectious Diseases and CBRN Threats" call for proposals of the France 2030
Robert Mamoun Kostenloser Wertpapierhandel Nicolas Merigeau Arthur Rouill Bpifrance Bpifrancepresse Institut Pasteur University Of Montpellier
Source: finanznachrichten.de